The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
HIV drug development: the next 25 years
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,209
Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection
Mellors, J. W., Munoz, A., Giorgi, J. V., Margolick, J. B., Tassoni, C. J., Gupta, P., Kingsley, L. A., Todd, J. A., Saah, A. J., Detels, R., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-12-199706150-00003 · Cited by 2,067
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
Coffin, J. M. (1995) · Science · doi:10.1126/science.7824947 · Cited by 1,981
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa062744 · Cited by 1,521
The role of a mutant CCR5 allele in HIV–1 transmission and disease progression
Huang, Y., Paxton, W. A., Wolinsky, S. M., Neumann, A. U., Zhang, L., He, T., Kang, S., Ceradini, D., Jin, Z., Yazdanbakhsh, K., et al. (1996) · Nature Medicine · doi:10.1038/nm1196-1240 · Cited by 1,358
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
Gallant, J. E., DeJesus, E., Arribas, J. R., Pozniak, A. L., Gazzard, B., Campo, R. E., Lu, B., McColl, D., Chuck, S., Enejosa, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051871 · Cited by 880
Genetic variations in HLA-B region and hypersensitivity reactions to abacavir
Hetherington, S., Hughes, A. R., Mosteller, M., Shortino, D., Baker, K. L., Spreen, W., Lai, E., Davies, K., Handley, A., Dow, D. J., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08158-8 · Cited by 807
Haas, D. W., Ribaudo, H. J., Kim, R. B., Tierney, C., Wilkinson, G. R., Gulick, R. M., Clifford, D. B., Hulgan, T., Marzolini, C., & Acosta, E. P. (2004) · PubMed · Cited by 627
CCR5 deficiency increases risk of symptomatic West Nile virus infection
Glass, W. G., McDermott, D. H., Lim, J. K., Lekhong, S., Yu, S. F., Frank, W. A., Pape, J., Cheshier, R. C., & Murphy, P. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051970 · Cited by 519
Martin, A. M., Nolan, D., Gaudieri, S., Almeida, C. A., Nolan, R., James, I., Carvalho, F., Phillips, E., Christiansen, F. T., Purcell, A. W., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307067101 · Cited by 452
Li, F., Goila-Gaur, R., Salzwedel, K., Kilgore, N. R., Reddick, M., Matallana, C., Castillo, A., Zoumplis, D., Martin, D. E., Orenstein, J. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234683100 · Cited by 426
Lewis, S. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200407010-00001 · Cited by 423
Markowitz, M., Morales-Ramirez, J. O., Nguyen, B.-Y., Kovacs, C. M., Steigbigel, R. T., Cooper, D. A., Liporace, R., Schwartz, R., Isaacs, R., Gilde, L. R., et al. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31802b4956 · Cited by 368
Hendrix, C. W., Collier, A. C., Lederman, M. M., Schols, D., Pollard, R. B., Brown, S., Jackson, J. B., Coombs, R. W., Glesby, M. J., Flexner, C. W., et al. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000137371.80695.ef · Cited by 366
Self-citationLethal mutagenesis of HIV with mutagenic nucleoside analogs
Loeb, L. A., Essigmann, J. M., Kazazi, F., Zhang, J., Rose, K. D., & Mullins, J. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1492 · Cited by 357
Westby, M., Smith-Burchnell, C., Mori, J., Lewis, M., Mosley, M., Stockdale, M., Dorr, P., Ciaramella, G., & Perros, M. (2007) · Journal of Virology · doi:10.1128/jvi.02006-06 · Cited by 350
Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy
Greene, W. C., & Peterlin, B. M. (2002) · Nature Medicine · doi:10.1038/nm0702-673 · Cited by 296
The HBV Drug Entecavir — Effects on HIV-1 Replication and Resistance
McMahon, M. A., Jilek, B. L., Brennan, T. P., Shen, L., Zhou, Y., Wind-Rotolo, M., Xing, S., Bhat, S., Hale, B., Hegarty, R., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067710 · Cited by 292
Big physics, small doses: the use of AMS and PET in human microdosing of development drugs
Lappin, G., & Garner, R. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1037 · Cited by 260
APOBEC-Mediated Editing of Viral RNA
Bishop, K. N., Holmes, R. K., Sheehy, A. M., & Malim, M. H. (2004) · Science · doi:10.1126/science.1100658 · Cited by 247
Gulick, R. M., Su, Z., Flexner, C., Hughes, M. D., Skolnik, P. R., Wilkin, T. J., Gross, R., Krambrink, A., Coakley, E., Greaves, W. L., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/518797 · Cited by 239
Self-citationBartlett, J. G. (1998) · PubMed · Cited by 238
Benson, C. A., Williams, P. L., Currier, J. S., Holland, F., Mahon, L. F., MacGregor, R. R., Inderlied, C. B., Flexner, C. W., Neidig, J. L., Chaisson, R. E., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/378807 · Cited by 142
Self-citationStone, N. D., Dunaway, S. B., Flexner, C. W., Tierney, C., Calandra, G., Becker, S. L., Cao, Y.-J., Wiggins, I. P., Conley, J., MacFarland, R. T., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00013-07 · Cited by 134
Self-citationOut of Africa: what can we learn from HIV-2 about protective immunity to HIV-1?
Rowland‐Jones, S., & Whittle, H. C. (2007) · Nature Immunology · doi:10.1038/ni0407-329 · Cited by 125
Eron, J. J., Feinberg, J., Kessler, H. A., Horowitz, H. W., Witt, M. D., Carpio, F., Wheeler, D. A., Ruane, P. J., Mildvan, D., Yangco, B. G., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/380799 · Cited by 122
Johnson, M. A., Gathe, J., Podzamczer, D., Molina, J., Naylor, C., Chiu, Y., King, M. S., Podsadecki, T. J., Hanna, G. J., & Brun, S. C. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000242449.67155.1a · Cited by 116
Declining CD4 T-Cell Counts in a Person Infected withnef-Deleted HIV-1
Greenough, T. C., Sullivan, J. L., & Desrosiers, R. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400314 · Cited by 106
Lampe, F. C., Gatell, J. M., Staszewski, S., Johnson, M. A., Pradier, C., Gill, M. J., de Lazzari, E., Dauer, B., Youle, M. S., Fontas, É., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.5.521 · Cited by 90
Moore, R. D., Keruly, J. C., Gebo, K. A., & Lucas, G. M. (2005) · PubMed · Cited by 88
Swindells, S. (2006) · JAMA · doi:10.1001/jama.296.7.806 · Cited by 84
Haubrich, R., Flexner, C. W., Lederman, M. M., Hirsch, M., Pettinelli, C., Ginsberg, R. S., Lietman, P. S., Hamzeh, F. M., Spector, S. A., & Richman, D. D. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/172.5.1246 · Cited by 38
Self-citation
Cited by
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
Genome-Scale RNAi Screen for Host Factors Required for HIV Replication
Zhou, H., Xu, M., Huang, Q., Gates, A. T., Zhang, X. D., Castle, J. C., Stec, E., Ferrer, M., Strulovici, B., Hazuda, D. J., et al. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.10.004 · Cited by 789
Keri, R. S., Patil, M. R., Patil, S. A., & Budagumpi, S. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.059 · Cited by 631
The structural biology of HIV-1: mechanistic and therapeutic insights
Engelman, A., & Cherepanov, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2747 · Cited by 424
Metadata
- Authors
- Flexner, C.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-12
- Volume
- 6
- Issue
- 12
- Pages
- 959-966
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2116893683
- Cited by
- 317
- References
- 32
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.